KG
KURA icon

Kilter Group’s Kura Oncology KURA Stock Holding History

Kilter Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40
Closed -$231 – 1285
2025
Q2 		$231 Buy
+40
New +$245 ﹤0.01% 1090

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Kilter Group's KURA Position: Q3 2025 in Review

Kilter Group sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 40 shares — an estimated $231 sold.

Kilter Group first reported a position in KURA in Q2 2025 and held it in 1 quarter. The position peaked at $231 in Q2 2025. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Kilter Group reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
  • Kilter Group sold 40 Kura Oncology shares in Q3 2025, an estimated $231.
  • Kilter Group first reported a position in Kura Oncology in Q2 2025 and held it in 1 quarter.
  • Kilter Group's Kura Oncology position peaked at $231 in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Kilter Group's 13F filing for Q3 2025, filed 6 Feb 2026.